Different roles of α2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the rat

R. Gáspár, Adrienn Gál, Márta Gálik, Eszter Ducza, Renáta Minorics, Zoltán Kolarovszki-Sipiczki, Anna Klukovits, G. Falkay

Research output: Article

23 Citations (Scopus)

Abstract

The roles of the α2-adrenoceptor (α2-AR) subtypes (α2A-, α2B- and α2C-AR) in uterine contractility have not been investigated. The aims of this study were to identify these receptors in the non-pregnant and the late-pregnant rat myometrium and to determine their roles in contractions. We found that the myometrial α2-AR subtypes are involved differently in the control of late-pregnant contractions, while they have no influence on the contractions of the non-pregnant myometrium. The myometrial expressions of the α2-AR subtypes were determined by RT-PCR and Western blotting techniques. In vitro contractions were stimulated with noradrenaline, and its effect was modified with the selective antagonists BRL 44408 (α2A), ARC 239 (α2B/C) and spiroxatrine (α2C). cAMP production was followed by noradrenaline stimulation in the presence of isobutylmethylxanthine and forskolin, and alterations induced in it by the antagonists were determined with an Enzyme Immunoassay Kit. The most effective antagonist was tested on labour-induced uteri in vitro. All the α2-AR subtypes were identified in both non-pregnant and pregnant uteri. Noradrenaline was not able to contract the non-pregnant tissue in the presence of propranolol and doxazosin, while its contracting effect in the pregnant uteri was enhanced by BRL 44408, spiroxatrine and the combination BRL 44408 + spiroxatrine. ARC 239 exerted a strong inhibitory effect on noradrenaline-stimulated contractions. The increasing and the decreasing effects of the compounds were confirmed by the changes in the intracellular cAMP levels. The effect of ARC 239 on the labour-induced myometrium was similar to that on the 22-day-pregnant myometrium. The stimulation of α2-ARs does not evoke contractions in the non-pregnant uterus. The α2A- and α2C-ARs mediate decreases, while the α2B-AR mediates an increase in the contractions in the 22-day-pregnant myometrium. These differences may offer new targets for drugs against premature contractions in pregnancy.

Original languageEnglish
Pages (from-to)311-318
Number of pages8
JournalNeurochemistry International
Volume51
Issue number5
DOIs
Publication statusPublished - okt. 2007

Fingerprint

spiroxatrine
Myometrium
Adrenergic Receptors
Uterus
Norepinephrine
Induced Labor
Doxazosin
Colforsin
Immunoenzyme Techniques
Propranolol
Western Blotting
In Vitro Techniques
Pregnancy
Polymerase Chain Reaction
Pharmaceutical Preparations
AR-C239
BRL 44408

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Different roles of α2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the rat. / Gáspár, R.; Gál, Adrienn; Gálik, Márta; Ducza, Eszter; Minorics, Renáta; Kolarovszki-Sipiczki, Zoltán; Klukovits, Anna; Falkay, G.

In: Neurochemistry International, Vol. 51, No. 5, 10.2007, p. 311-318.

Research output: Article

Gáspár, R. ; Gál, Adrienn ; Gálik, Márta ; Ducza, Eszter ; Minorics, Renáta ; Kolarovszki-Sipiczki, Zoltán ; Klukovits, Anna ; Falkay, G. / Different roles of α2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the rat. In: Neurochemistry International. 2007 ; Vol. 51, No. 5. pp. 311-318.
@article{d063561d049f40849502c008f2f2057c,
title = "Different roles of α2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the rat",
abstract = "The roles of the α2-adrenoceptor (α2-AR) subtypes (α2A-, α2B- and α2C-AR) in uterine contractility have not been investigated. The aims of this study were to identify these receptors in the non-pregnant and the late-pregnant rat myometrium and to determine their roles in contractions. We found that the myometrial α2-AR subtypes are involved differently in the control of late-pregnant contractions, while they have no influence on the contractions of the non-pregnant myometrium. The myometrial expressions of the α2-AR subtypes were determined by RT-PCR and Western blotting techniques. In vitro contractions were stimulated with noradrenaline, and its effect was modified with the selective antagonists BRL 44408 (α2A), ARC 239 (α2B/C) and spiroxatrine (α2C). cAMP production was followed by noradrenaline stimulation in the presence of isobutylmethylxanthine and forskolin, and alterations induced in it by the antagonists were determined with an Enzyme Immunoassay Kit. The most effective antagonist was tested on labour-induced uteri in vitro. All the α2-AR subtypes were identified in both non-pregnant and pregnant uteri. Noradrenaline was not able to contract the non-pregnant tissue in the presence of propranolol and doxazosin, while its contracting effect in the pregnant uteri was enhanced by BRL 44408, spiroxatrine and the combination BRL 44408 + spiroxatrine. ARC 239 exerted a strong inhibitory effect on noradrenaline-stimulated contractions. The increasing and the decreasing effects of the compounds were confirmed by the changes in the intracellular cAMP levels. The effect of ARC 239 on the labour-induced myometrium was similar to that on the 22-day-pregnant myometrium. The stimulation of α2-ARs does not evoke contractions in the non-pregnant uterus. The α2A- and α2C-ARs mediate decreases, while the α2B-AR mediates an increase in the contractions in the 22-day-pregnant myometrium. These differences may offer new targets for drugs against premature contractions in pregnancy.",
keywords = "α-Adrenoceptors, cAMP, Pregnancy, Premature labour, Rat, Subtype-selective antagonists, Uterus",
author = "R. G{\'a}sp{\'a}r and Adrienn G{\'a}l and M{\'a}rta G{\'a}lik and Eszter Ducza and Ren{\'a}ta Minorics and Zolt{\'a}n Kolarovszki-Sipiczki and Anna Klukovits and G. Falkay",
year = "2007",
month = "10",
doi = "10.1016/j.neuint.2007.06.029",
language = "English",
volume = "51",
pages = "311--318",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Different roles of α2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the rat

AU - Gáspár, R.

AU - Gál, Adrienn

AU - Gálik, Márta

AU - Ducza, Eszter

AU - Minorics, Renáta

AU - Kolarovszki-Sipiczki, Zoltán

AU - Klukovits, Anna

AU - Falkay, G.

PY - 2007/10

Y1 - 2007/10

N2 - The roles of the α2-adrenoceptor (α2-AR) subtypes (α2A-, α2B- and α2C-AR) in uterine contractility have not been investigated. The aims of this study were to identify these receptors in the non-pregnant and the late-pregnant rat myometrium and to determine their roles in contractions. We found that the myometrial α2-AR subtypes are involved differently in the control of late-pregnant contractions, while they have no influence on the contractions of the non-pregnant myometrium. The myometrial expressions of the α2-AR subtypes were determined by RT-PCR and Western blotting techniques. In vitro contractions were stimulated with noradrenaline, and its effect was modified with the selective antagonists BRL 44408 (α2A), ARC 239 (α2B/C) and spiroxatrine (α2C). cAMP production was followed by noradrenaline stimulation in the presence of isobutylmethylxanthine and forskolin, and alterations induced in it by the antagonists were determined with an Enzyme Immunoassay Kit. The most effective antagonist was tested on labour-induced uteri in vitro. All the α2-AR subtypes were identified in both non-pregnant and pregnant uteri. Noradrenaline was not able to contract the non-pregnant tissue in the presence of propranolol and doxazosin, while its contracting effect in the pregnant uteri was enhanced by BRL 44408, spiroxatrine and the combination BRL 44408 + spiroxatrine. ARC 239 exerted a strong inhibitory effect on noradrenaline-stimulated contractions. The increasing and the decreasing effects of the compounds were confirmed by the changes in the intracellular cAMP levels. The effect of ARC 239 on the labour-induced myometrium was similar to that on the 22-day-pregnant myometrium. The stimulation of α2-ARs does not evoke contractions in the non-pregnant uterus. The α2A- and α2C-ARs mediate decreases, while the α2B-AR mediates an increase in the contractions in the 22-day-pregnant myometrium. These differences may offer new targets for drugs against premature contractions in pregnancy.

AB - The roles of the α2-adrenoceptor (α2-AR) subtypes (α2A-, α2B- and α2C-AR) in uterine contractility have not been investigated. The aims of this study were to identify these receptors in the non-pregnant and the late-pregnant rat myometrium and to determine their roles in contractions. We found that the myometrial α2-AR subtypes are involved differently in the control of late-pregnant contractions, while they have no influence on the contractions of the non-pregnant myometrium. The myometrial expressions of the α2-AR subtypes were determined by RT-PCR and Western blotting techniques. In vitro contractions were stimulated with noradrenaline, and its effect was modified with the selective antagonists BRL 44408 (α2A), ARC 239 (α2B/C) and spiroxatrine (α2C). cAMP production was followed by noradrenaline stimulation in the presence of isobutylmethylxanthine and forskolin, and alterations induced in it by the antagonists were determined with an Enzyme Immunoassay Kit. The most effective antagonist was tested on labour-induced uteri in vitro. All the α2-AR subtypes were identified in both non-pregnant and pregnant uteri. Noradrenaline was not able to contract the non-pregnant tissue in the presence of propranolol and doxazosin, while its contracting effect in the pregnant uteri was enhanced by BRL 44408, spiroxatrine and the combination BRL 44408 + spiroxatrine. ARC 239 exerted a strong inhibitory effect on noradrenaline-stimulated contractions. The increasing and the decreasing effects of the compounds were confirmed by the changes in the intracellular cAMP levels. The effect of ARC 239 on the labour-induced myometrium was similar to that on the 22-day-pregnant myometrium. The stimulation of α2-ARs does not evoke contractions in the non-pregnant uterus. The α2A- and α2C-ARs mediate decreases, while the α2B-AR mediates an increase in the contractions in the 22-day-pregnant myometrium. These differences may offer new targets for drugs against premature contractions in pregnancy.

KW - α-Adrenoceptors

KW - cAMP

KW - Pregnancy

KW - Premature labour

KW - Rat

KW - Subtype-selective antagonists

KW - Uterus

UR - http://www.scopus.com/inward/record.url?scp=34548480729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548480729&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2007.06.029

DO - 10.1016/j.neuint.2007.06.029

M3 - Article

C2 - 17664026

AN - SCOPUS:34548480729

VL - 51

SP - 311

EP - 318

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 5

ER -